[
    [
        {
            "time": "2020-05-18",
            "original_text": "金域医学股东君睿祺及一致行动人君联茂林拟减持1202万股，比例不超过2.62%。",
            "features": {
                "keywords": [
                    "金域医学",
                    "君睿祺",
                    "君联茂林",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学股东君睿祺及一致行动人君联茂林拟减持1202万股，比例不超过2.62%。",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-18",
            "original_text": "金域医学：2020年坚持医检服务主航道，推进全国实验室网络科学化布局。",
            "features": {
                "keywords": [
                    "金域医学",
                    "医检服务",
                    "实验室网络",
                    "科学化布局"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "金域医学：2020年坚持医检服务主航道，推进全国实验室网络科学化布局。",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2020-05-18",
            "original_text": "金域医学：股东拟减持不超过2.62%股份。",
            "features": {
                "keywords": [
                    "金域医学",
                    "股东",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学：股东拟减持不超过2.62%股份。",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-18",
            "original_text": "金域医学：股东君睿祺及其一致行动人拟清仓式减持不超过总股本2.62%。",
            "features": {
                "keywords": [
                    "金域医学",
                    "君睿祺",
                    "一致行动人",
                    "清仓式减持",
                    "股份"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学：股东君睿祺及其一致行动人拟清仓式减持不超过总股本2.62%。",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-18",
            "original_text": "金域医学(603882.SH)：君睿祺及君联茂林拟减持不超过2.62%的股份。",
            "features": {
                "keywords": [
                    "金域医学",
                    "君睿祺",
                    "君联茂林",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学(603882.SH)：君睿祺及君联茂林拟减持不超过2.62%的股份。",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-18",
            "original_text": "金域医学：君睿祺及其一致行动人拟合计减持不超过2.62%股份。",
            "features": {
                "keywords": [
                    "金域医学",
                    "君睿祺",
                    "一致行动人",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学：君睿祺及其一致行动人拟合计减持不超过2.62%股份。",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]